(Q54403954)

29 May 2018

title

Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer. (English)

1 reference

29 May 2018

author

Martin Peifer

5

1 reference

29 May 2018

Mark Rubin

15

1 reference

29 May 2018

Roopika Menon

1

object named as

Roopika Menon

1 reference

29 May 2018

author name string

Mario Deng

2

1 reference

29 May 2018

Kerstin Rüenauver

3

1 reference

29 May 2018

Angela Queisser

4

1 reference

29 May 2018

Anne Offermann

6

1 reference

29 May 2018

Diana Boehm

7

1 reference

29 May 2018

Wenzel Vogel

8

1 reference

29 May 2018

Veit Scheble

9

1 reference

29 May 2018

Falko Fend

10

1 reference

29 May 2018

Glen Kristiansen

11

1 reference

29 May 2018

Nicolas Wernert

12

1 reference

29 May 2018

Nicole Oberbeckmann

13

1 reference

29 May 2018

Saskia Biskup

14

1 reference

29 May 2018

Zaki Shaikhibrahim

16

1 reference

29 May 2018

Sven Perner

17

1 reference

29 May 2018

publication date

1 December 2013

1 reference

29 May 2018

published in

Journal of Pathology

1 reference

29 May 2018

volume

231

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

505-516

1 reference

29 May 2018

cites work

Cancer statistics, 2010

1 reference

Common gene rearrangements in prostate cancer

21 January 2018

1 reference

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

21 January 2018

1 reference

Castration-resistant prostate cancer: mechanisms, targets, and treatment.

21 January 2018

1 reference

Therapeutic options for advanced prostate cancer: 2011 update

21 January 2018

1 reference

Abiraterone acetate: redefining hormone treatment for advanced prostate cancer

21 January 2018

1 reference

Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100.

21 January 2018

1 reference

Role of the TMPRSS2-ERG gene fusion in prostate cancer

21 January 2018

1 reference

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

21 January 2018

1 reference

Diagnostic and prognostic molecular biomarkers for prostate cancer

21 January 2018

1 reference

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

21 January 2018

1 reference

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate

21 January 2018

1 reference

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

21 January 2018

1 reference

Common structural and epigenetic changes in the genome of castration-resistant prostate cancer

21 January 2018

1 reference

The genomic complexity of primary human prostate cancer

21 January 2018

1 reference

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

Exome enrichment and SOLiD sequencing of formalin fixed paraffin embedded (FFPE) prostate cancer tissue

21 January 2018

1 reference

Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis

21 January 2018

1 reference

Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity

21 January 2018

1 reference

ERG rearrangement in small cell prostatic and lung cancer

21 January 2018

1 reference

BFAST: an alignment tool for large scale genome resequencing

21 January 2018

1 reference

The Sequence Alignment/Map format and SAMtools

21 January 2018

1 reference

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

21 January 2018

1 reference

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

21 January 2018

1 reference

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

21 January 2018

1 reference

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

21 January 2018

1 reference

14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.

21 January 2018

1 reference

TMPRSS2-ERG and PTEN loss in prostate cancer

21 January 2018

1 reference

Effect of paclitaxel on intracellular localization of c-Myc and P-c-Myc in prostate carcinoma cell lines

21 January 2018

1 reference

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

14-3-3ζ as a prognostic marker and therapeutic target for cancer

21 January 2018

1 reference

14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells

21 January 2018

1 reference

14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival

21 January 2018

1 reference

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion

21 January 2018

1 reference

Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma

21 January 2018

1 reference

Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis

21 January 2018

1 reference

Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx

21 January 2018

1 reference

Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo

21 January 2018

1 reference

Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo

21 January 2018

1 reference

Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer

21 January 2018

1 reference

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4274

1 reference

29 May 2018

1 reference

29 May 2018